Sentence examples for lower assay from inspiring English sources

The reliable lower assay limits for each were: CX3CL1-39.5 pg/mL, GM-CSF 3.02 pg/mL, VEGF-A 36.6 pg/mL.

Hence, the purpose of this review is to highlight some new strategic directions in DNA detection technologies in order to inspire development of novel molecular diagnostic tools and bio-assay systems with superior reliability, reproducibility, robustness, accuracy and sensitivity at lower assay cost.

As stated by the manufacturer, the lower assay limit for the LBP assay was 0.2 µg/ml, and the calibration ranged was up to 200 µg/ml, having a 103 linear dynamic range.

As expected, the methods for assigning genotypes (Figure 2) that require the greatest (0.1) separation of genotypes, methods B and D, had an approximately 10% lower assay success rate, than methods A and C, respectively (Figure 4).

The plasma samples were run in duplicate and data reported back as concentrations (average of two independent measures), together with normative data such as least detectable dose (determined as the mean ±3 standard deviations of 20 blank readings) and lower assay limit (assay working sensitivity defined by the lowest concentration calibrator used for quantitation).

The difference in prevalence may be due to lower assay sensitivity or suboptimal specimen collection and storage methods employed in the earlier study.

Quantitative real-time RT-PCR with TaqMan® Low density array (TLDA) was used to measure gene expression, allowing analysis of all the selected genes in several samples at the same time lowering assay variation and increasing reproducibility.

We explored possible factors lowering assay success rate by predicting exon-intron boundaries and paralogous genes of Acacia contigs using Medicago truncatula genome as reference.

For example, microplates have evolved from 96 384 wells to up to 3456 wells, lowering assay cost owing to the reduction of the amount of reagents and samples [ 1, 2].

Moreover, while a recently published cost analysis of mass fetal RHD genotyping suggested that the costs of introducing such a service would not be met by the reduction in use of prophylactic antenatal Anti-D Ig, [ 21] others have argue that automated testing lowers assay costs below the price of Anti-D Ig and is cost-effective [ 22].

As a result, this can simplify experimental protocols, lower the assay cost, and provide amenability to miniaturisation.